Antares Pharma (Antares Pharma) Inventory Turnover : 1.62 (As of Mar. 2022)

View and export this data going back to 1996. Start your Free Trial

What is Antares Pharma Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Antares Pharma's Cost of Goods Sold for the three months ended in Mar. 2022 was $18.8 Mil. Antares Pharma's Average Total Inventories for the quarter that ended in Mar. 2022 was $11.6 Mil. Antares Pharma's Inventory Turnover for the quarter that ended in Mar. 2022 was 1.62.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Antares Pharma's Days Inventory for the three months ended in Mar. 2022 was 56.24.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Antares Pharma's Inventory-to-Revenue for the quarter that ended in Mar. 2022 was 0.28.

Antares Pharma Inventory Turnover Historical Data

The historical data trend for Antares Pharma's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antares Pharma Inventory Turnover Chart

Antares Pharma Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Inventory Turnover

Get a 7-Day Free Trial

3.76

3.01

3.69

4.59

Antares Pharma Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Inventory Turnover	Get a 7-Day Free Trial															0.87	0.86	0.94	1.35	1.62

Antares Pharma Inventory Turnover Calculation

Antares Pharma's Inventory Turnover for the fiscal year that ended in Dec. 2021 is calculated as

	Inventory Turnover (A: Dec. 2021 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2021 )	/ (	(Total Inventories (A: Dec. 2020 )	+	Total Inventories (A: Dec. 2021 ))	/	count )
=	68.281	/ (	(18.216	+	11.544)	/	2 )
=	68.281	/	14.88
=	4.59

Antares Pharma's Inventory Turnover for the quarter that ended in Mar. 2022 is calculated as

	Inventory Turnover (Q: Mar. 2022 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2022 )	/ (	(Total Inventories (Q: Dec. 2021 )	+	Total Inventories (Q: Mar. 2022 ))	/	count )
=	18.767	/ (	(11.544	+	11.591)	/	2 )
=	18.767	/	11.5675
=	1.62

Antares Pharma (NAS:ATRS) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Antares Pharma's Days Inventory for the three months ended in Mar. 2022 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2022 )	/	Cost of Goods Sold (Q: Mar. 2022 )	*	Days in Period
	=	11.5675	/	18.767	*	365 / 4
	=	56.24

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Antares Pharma's Inventory to Revenue for the quarter that ended in Mar. 2022 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2022 )	/	Revenue (Q: Mar. 2022 )
	=	11.5675	/	41.557
	=	0.28

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Antares Pharma Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Antares Pharma's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Antares Pharma (Antares Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Antares Pharma Inc (NAS:ATRS) » Definitions » Inventory Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Princeton South, Suite 300, Ewing, NJ, USA, 08628

Website

https://www.antarespharma.com

Antares Pharma Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. The company's products include OTREXUP, Elestrin, Gelnique, Makena, and others.

Executives

Karen L. Smith	director	C/O JAZZ PHARMACEUTICALS PLC, 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN L2 4 L2
Carmen B Volkart	director	C/O MODULAR MEDICAL, INC., 16772 WEST BERNARDO DRIVE, SAN DIEGO CA 92127
Peter C Richardson	officer: See Remarks	28903 NORTH AVENUE PAINE, VALENCIA CA 91355
Fred M Powell	officer: Executive Vice President & CFO	C/O BEJING MED-PHARM CORPORATION 600 W. GERMANTOWN PIKE, SUITE 400 PLYMOUTH MEETING PA 19462
Thomas J Garrity	director
Roche Robert P Jr	director	41 MOORES ROAD FRAZER PA 19355
Leonard S Jacob	director	C/O INKINE PHARMACEUTICAL COMPANY INC 425 PARK AVENUE NEW YORK NY 10022
Peter J Graham	officer: See Remarks	315 E. 72ND ST., APT 5E, NEW YORK NY 10021
Peter Greenleaf	director	ONE MEDIMMUNE WAY, GAITHERSBURG MD 20878
Anton Gueth	director
Robert F Apple	director, officer: President & CEO	C/O INKLINE PHARMACEUTICAL CO INC SENTRY PARK EAST 1720 WALTON ROAD BLUE BELL PA 19422
Marvin Samson	director
Jacques Gonella	director	C/O ANTARES PHARMA INC 707 EAGLEVIEW BLVD SUITE 414 EXTON PA 19341
James Patrick Tursi	officer: EVP, Chief Medical Officer	106 ASHLEY COURT, MOORESTOWN NJ 08057
Keith E Muckenhirn	officer: VP/Controller & Interim CFO	C/O ANTARES PHARMA, INC. 3905 ANNAPOLIS LANE N, SUITE 105 PLYMOUTH MN 55447